Health Condition 1: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: Topical Finasteride: Patient is instructed to apply 1 ml of Topical Finasteride 0.25% solution, prepared in alcohol base, over affected area of scalp twice daily, for 6 months.
Control
Sponsors
Lady Hardinge Medical College
Eligibility
Inclusion criteria
Inclusion criteria: 1. All new male patients with clinically diagnosed androgenetic alopecia of grade III or higher (Modified Norwood Hamilton classification)
Exclusion criteria
Exclusion criteria: 1. Patients who have used any topical or systemic drugs in the past 6 months to promote hair growth 2. Patients with other scalp diseases that affect hair growth including seborrheic capitis 3. Patients with elevated levels of serum prostate specific antigen (PSA) 4. Patients with thyroid abnormality or vitamin D deficiency 5. Patients with history of continuing intake of following drugs â?? antihypertensives, antiepileptics, cytotoxic drugs, systemic corticosteroids, bronchodilators and vasodilators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in one or more of the following parameters in the three groups: 1. Mean Physician Assessment score (PAS) 2. Mean change in hair density from baseline 3. Mean change in number of terminal and vellus hair from baselineTimepoint: 12 and 24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean Patient Satisfaction Scores (PSS)Timepoint: 12 and 24 weeks;Proportion of patients experiencing side effects in the three groupsTimepoint: 12 and 24 weeks | — |
Countries
India
Contacts
Public ContactDr Ram Chander
Lady Hardinge Medical College
Outcome results
None listed